NEOADJUVANT CHEMORADIOTHERAPY WITH SEQUENTIAL IPILIMUMAB AND NIVOLUMAB IN RECTAL CANCER (CHINOREC): A PROSPECTIVE RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II CLINICAL TRIAL

被引:1
作者
Laengle, J. [1 ,2 ]
Kuehrer, I. [1 ]
Pils, D. [1 ]
Kabiljo, J. [1 ]
Woeran, K. [3 ]
Stift, J. [3 ]
Herbst, F. [4 ]
Dauser, B. [4 ]
Monschein, M. [5 ]
Razek, P. [5 ]
Haegele, S. [6 ]
Herac, M. [7 ]
Hulla, W. [7 ]
Bitterman, C. [8 ]
Laengle, F. [8 ]
Tamandl, D. [9 ]
Widder, J. [10 ]
Schmid, R. [10 ]
Bergmann, M. [1 ]
机构
[1] Med Univ Vienna, Div Gen Surg, Dept Surg, Comprehens Canc Ctr Vienna, Vienna, Austria
[2] Med Univ Vienna, Ludwig Boltzmann Inst Appl Diagnost, Vienna, Austria
[3] Med Univ Vienna, Dept Pathol, Comprehens Canc Ctr Vienna, Vienna, Austria
[4] Hosp St John God, Dept Surg, Vienna, Austria
[5] Clin Floridsdorf, Dept Surg, Vienna, Austria
[6] Clin Floridsdorf, Dept Pathol, Vienna, Austria
[7] State Hosp Wiener Neustadt, Inst Pathol, Wiener Neustadt, Austria
[8] State Hosp Wiener Neustadt, Dept Surg, Wiener Neustadt, Austria
[9] Med Univ Vienna, Div Gen & Pediat Radiol, Dept Biomed Imaging & Image Guided Therapy, Comprehens Canc Ctr Vienna, Vienna, Austria
[10] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Radiotherapy, Vienna, Austria
关键词
D O I
10.1136/jitc-2020-ITOC7.100
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P08.04
引用
收藏
页码:A51 / A51
页数:1
相关论文
empty
未找到相关数据